Skip to content 
Nucala
Nucala (mepolizumab) is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma. Resources Contact Us Administration Information Nucala is administered as an injection every 4 weeks. An observation time may be required after your injection. 1 Dose Injection every 4 weeks Potential Side Effects The most common side effects of […]
Leqvio
With Leqvio, people in clinical studies on a maximally tolerated statin lowered their cholesterol by 50% and kept it low during each 6-month dosing interval vs placebo. LEQVIO (inclisiran) is an injectable prescription medicine used along with diet and other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type […]
Krystexxa
Krystexxa is a PEGylated uric acid-specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Krystexxa has a different way of lowering uric acid levels, which is the key to stopping gout flares. In about 6 months, it can safely and effectively remove years of uric acid crystal buildup […]
IV Hydration
IV therapy infusions involves inserting an IV line into a vein in your arm to administer fluids. IV hydration treats dehydration.Dehydration can be caused by decreased oral intake, diarrhea/vomiting, sweating, fever, or urinating too much (which can happen because of certain medications and illnesses). Certain people are at risk for dehydration, such as older adults, […]
Inflectra
Inflectra (Infliximab-dyyb) is a biosimilar of Remicade. It is indicated for the treatment of Crohn’s Disease, pediatric Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis. Inflectra is administered as an intravenous infusion. Resources Contact Us Administration Information Inflectra infusions are generally administered every six to eight weeks, and infusions are […]
Ilumya
ILUMYA is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Resources Contact Us Administration Information It is given as a subcutaneous injection at Weeks 0, 4, and every twelve weeks thereafter 2 Initial Doses – Week 0 & 4 1 Then Every […]
Orencia
Orencia is used to reduce signs and symptoms of moderate to severe Rheumatoid Arthritis in adults 18 years and older. Taking Orencia may prevent further damage to your bones and joints, and may help your ability to perform daily activities. Orencia may help those who are not getting the results they need with other medicines […]
Glassia
Glassia is an Alpha1 -Proteinase Inhibitor (Human), indicated for chronic augmentation and maintenance therapy in individuals with clinically evident emphysema due to severe hereditary deficiency of Alpha1 -PI, also known as alpha1 -antitrypsin (AAT) deficiency. Glassia increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1 […]
Ocrevus
Ocrevus is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adultsPrimary progressive MS, in adults Resources Contact Us Administration Information Ocrevus is an intravenous infusion that is given every 6 months. Your first dose will be split into […]
Prolia
Prolia (denosumab) is indicated for: Treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Treatment to increase bone mass in men with osteoporosis at high risk for […]
